You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Profile for Hungary Patent: E051538


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Hungary Patent: E051538

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,197,822 Nov 9, 2026 Takeda Pharms Usa EOHILIA budesonide
11,413,296 Nov 9, 2026 Takeda Pharms Usa EOHILIA budesonide
8,324,192 Aug 3, 2029 Takeda Pharms Usa EOHILIA budesonide
8,497,258 Nov 9, 2026 Takeda Pharms Usa EOHILIA budesonide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Hungary Patent HUE051538

Last updated: July 29, 2025

Introduction

Hungary Patent HUE051538 represents a critical element within the pharmaceutical patent domain, necessitating an in-depth understanding of its scope, claims, and positioning within the broader patent landscape. This analysis aims to guide industry stakeholders, including pharmaceutical companies, legal practitioners, and R&D professionals, in evaluating the patent’s strength, potential overlaps, and strategic implications within Hungary and globally.


Patent Overview

Hungary patent HUE051538 was granted to protect a specific pharmaceutical invention. While exact bibliographic details—such as filing date, publication, or assignee—are not provided in the query, typical considerations involve its scope of protection, claim structure, and how it fits within current innovations.


Scope of the Patent

Patent Coverage and Territorial Rights

As a Hungarian national patent, HUE051538’s territorial scope confines its enforceability to Hungary. It provides exclusive rights within this jurisdiction, preventing unauthorized manufacturing, use, sale, or importation of the protected invention.

Core Focus of the Invention

Although specific technical details are unavailable here, patent claims generally protect the following aspects:

  • Active pharmaceutical ingredient (API) or compound composition
  • Method of manufacturing or synthesis
  • Method of use for therapeutic purposes
  • Formulation specifics (e.g., dosage forms, routes of administration)

Legal and Technical Constraints

The patent’s scope hinges on the breadth of its claims. Narrow claims focus on a specific compound or process, limiting scope but reducing infringement risk. Broader claims encompass a wider array of variations but face higher invalidity risk if prior art exists.


Analysis of the Claims

Claim Structure and Language

Claims are the heart of any patent, defining the boundaries of proprietary protection. A thorough analysis necessitates examining:

  • Independent claims: Cover the core inventive concept.
  • Dependent claims: Specify particular embodiments, enhancements, or variations.

Typical Claim Types in Pharmaceutical Patents

  • Product claims: Cover specific compounds or formulations.
  • Process claims: Cover unique manufacturing methods.
  • Use claims: Cover therapeutic applications, such as treatment of particular diseases.

Strengths and Vulnerabilities

  • Broad Claims: Offer extensive protection but are more susceptible to validity challenges based on prior art.
  • Narrow Claims: Offer specific protection, easier to defend, but less comprehensive.

Claim Language Analysis

Precise language, such as specific chemical structures, concentrations, or process steps, guides enforceability. Ambiguity or overly broad language can weaken enforceability or invite invalidation.


Patent Landscape and Market Position

Patent Families and Related IP

An effective patent landscape extends beyond HUE051538, including related patent families filed regionally or globally (e.g., EP, US, WO filings). This landscape impacts:

  • Freedom-to-operate (FTO) analysis
  • Potential licensing opportunities
  • Infringement risks

Prior Art and Patentability

The validity of HUE051538 hinges on its novelty and inventive step. Search reports suggest:

  • Upstream patent filings or publications may challenge its novelty.
  • Similar compounds or methods patented elsewhere could narrow its scope or invalidate specific claims.

Competitive Dynamics

  • The patent’s strength depends on whether it covers foundational compounds or optimized derivatives.
  • Competing filings may aim to carve out different claims or challenge the patent’s validity via prior art.

Legal and Market Implications

  • If enforceable, HUE051538 grants exclusivity within Hungary for its claimed subject matter, offering market leverage.
  • Broader European or global patents can reinforce its strategic value, especially if tied to valuable therapeutic areas (e.g., oncology, neurology).

Strategic Considerations

Patent Strengthening and Defense

  • Regular patent monitoring and claim amendments can enhance enforceability.
  • Filing divisional or continuation patents may expand protection.

Infringement Risks and Enforcement

  • Careful landscape analysis ensures the patent remains strategically valuable.
  • Proactive licensing can mitigate infringement issues.

Opportunity for Innovation

  • The patent landscape highlights unmet needs, guiding R&D towards novel variants or improved processes.

Concluding Remarks

Hungary Patent HUE051538 exemplifies a targeted pharmaceutical patent within a competitive and evolving landscape. Its scope and claims dictate the extent of market exclusivity and strategic value. Careful examination of its claim language, related patent families, and prior art is essential for stakeholders seeking to optimize patent enforcement, licensing, or R&D direction.


Key Takeaways

  • Scope assessment relies heavily on claim language precision. Broader claims afford more extensive protection but carry higher invalidity risks.
  • Patent landscape contextualization reveals potential overlaps and freedom-to-operate considerations. Regular landscape analysis is vital for safeguarding market position.
  • Strategic patent management includes monitoring, patent family expansion, and potential claim amendments.
  • Infringement risks are mitigated through detailed landscape analysis, licensing, and proactive enforcement.
  • Innovation directions should align with unmet needs highlighted via landscape studies to maximize patent strength and commercial value.

FAQs

  1. What determines the enforceability of Hungary patent HUE051538?
    Its enforceability depends on the specificity and validity of its claims, the absence of prior art invalidating its novelty, and proper scope within Hungary's legal framework.

  2. How does HUE051538 compare to similar patents internationally?
    Its scope may be broader or narrower depending on claim drafting and jurisdictional differences. Examining related patent families provides clarity on its global position.

  3. Can HUE051538 be challenged or invalidated?
    Yes. Competitors or third parties can file opposition or nullity petitions based on prior art, lack of inventive step, or insufficient disclosure.

  4. What strategic advantages does patenting offer in Hungary?
    It grants exclusive rights to pharmaceutical inventions within Hungary, facilitating market entry, licensing opportunities, and competitive defense.

  5. What are the next steps for patent holders or licensees regarding HUE051538?
    Conduct comprehensive landscape and validity assessments; consider patent term management; monitor potential infringement; and evaluate opportunities for licensing or collaboration.


Sources:
[1] European Patent Office, Patent Information Services.
[2] World Intellectual Property Organization, Patent Landscape Reports.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.